EE+ POEM Archive
Linagliptin does not increase (or decrease) risk of adverse CVD outcomes
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Linagliptin Does Not Increase (or Decrease) Risk of Adverse CVD Outcomes." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314679/all/Linagliptin does not increase (or decrease) risk of adverse CVD outcomes.
Linagliptin does not increase (or decrease) risk of adverse CVD outcomes. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314679/all/Linagliptin does not increase (or decrease) risk of adverse CVD outcomes. Accessed December 11, 2025.
Linagliptin does not increase (or decrease) risk of adverse CVD outcomes. (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314679/all/Linagliptin does not increase (or decrease) risk of adverse CVD outcomes
Linagliptin Does Not Increase (or Decrease) Risk of Adverse CVD Outcomes [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 December 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314679/all/Linagliptin does not increase (or decrease) risk of adverse CVD outcomes.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Linagliptin does not increase (or decrease) risk of adverse CVD outcomes
ID - 1314679
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314679/all/Linagliptin does not increase (or decrease) risk of adverse CVD outcomes
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
